Search

Author/Creator Ou, Ruizhang

1. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 12 (28th October 2019)

Authors:
Ye, Liping; Lin, Chuyong; Wang, Xi; Li, Qiji; Li, Yue; Wang, Meng; Zhao, Zekun; Wu, Xianqiu; Shi, Dongni; Xiao, Yunyun; Ren, Liangliang; Jian, Yunting; Yang, Meisongzhu; Ou, Ruizhang; Deng, Guangzheng; Ouyang, Ying; Chen, Xiangfu; Li, Jun; Song, Libing
Journal:
EMBO molecular medicine
Issue:
Volume 11:Issue 12(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 12 (28th October 2019)

Authors:
Ye, Liping; Lin, Chuyong; Wang, Xi; Li, Qiji; Li, Yue; Wang, Meng; Zhao, Zekun; Wu, Xianqiu; Shi, Dongni; Xiao, Yunyun; Ren, Liangliang; Jian, Yunting; Yang, Meisongzhu; Ou, Ruizhang; Deng, Guangzheng; Ouyang, Ying; Chen, Xiangfu; Li, Jun; Song, Libing
Journal:
EMBO molecular medicine
Issue:
Volume 11:Issue 12(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. Issue 3 (7th March 2022)

Authors:
Ye, Liping; Lin, Chuyong; Wang, Xi; Li, Qiji; Li, Yue; Wang, Meng; Zhao, Zekun; Wu, Xianqiu; Shi, Dongni; Xiao, Yunyun; Ren, Liangliang; Jian, Yunting; Yang, Meisongzhu; Ou, Ruizhang; Deng, Guangzheng; Ouyang, Ying; Chen, Xiangfu; Li, Jun; Song, Libing
Journal:
EMBO molecular medicine
Issue:
Volume 14:Issue 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search